Ara-290
An EPO-derived peptide studied for neuropathic pain, small fiber neuropathy, and tissue protection.
Deltorphin refers to a family of highly selective delta opioid receptor agonist peptides. Researchers study these peptides for their potent pain-relieving properties.
In the literature, Deltorphin appears most often in work focused on pain research and nerve pain. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Deltorphin is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
An EPO-derived peptide studied for neuropathic pain, small fiber neuropathy, and tissue protection.
A potent opioid-receptor peptide used strictly in analgesic and receptor research.
Atosiban is a synthetic competitive antagonist of the oxytocin receptor, developed to suppress premature uterine contractions. It is used as a tocolytic agent to treat preterm labor.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.